U.S. Markets closed
  • S&P 500

    3,629.65
    -5.76 (-0.16%)
     
  • Dow 30

    29,872.47
    -173.77 (-0.58%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • Russell 2000

    1,845.02
    -8.51 (-0.46%)
     
  • Crude Oil

    45.44
    -0.27 (-0.59%)
     
  • Gold

    1,814.30
    +8.80 (+0.49%)
     
  • Silver

    23.45
    +0.09 (+0.38%)
     
  • EUR/USD

    1.1936
    +0.0017 (+0.1432%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.25
    -0.39 (-1.80%)
     
  • GBP/USD

    1.3370
    -0.0013 (-0.0936%)
     
  • USD/JPY

    104.2770
    -0.1630 (-0.1561%)
     
  • BTC-USD

    17,460.84
    -518.33 (-2.88%)
     
  • CMC Crypto 200

    340.06
    -30.45 (-8.22%)
     
  • FTSE 100

    6,389.29
    -1.80 (-0.03%)
     
  • Nikkei 225

    26,537.31
    +240.45 (+0.91%)
     

Company News for Sep 24, 2020

Zacks Equity Research
·1 min read
  • Shares of JinkoSolar Holding Co., Ltd. JKS jumped nearly 21% after the company reported second-quarter 2020 earnings of 93 cents, beating the Zacks Consensus Estimate of 40 cents.

  • Johnson & Johnson’s JNJ shares rose 0.2% after the company reported that it had launched a global Phase 3 trial of its COVID-19 vaccine candidate.

  • Shares of SPI Energy Co., Ltd. SPI surged more than 100% after the company launched a new electric vehicle subsidiary.

  • MediciNova, Inc.’s MNOV shares rose 8.1% after the company reported its intranasal SARS-CoV-2 vaccine prototype for COVID-19, using BC-PIV technology has successfully induced systemic serum IgG and mucosal IgA neutralizing antibodies against the S1 antigen (Ag) of SARS-CoV-2 in mice.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Johnson Johnson (JNJ) : Free Stock Analysis Report
 
JinkoSolar Holding Company Limited (JKS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research